When should a 40‑year‑old man with migraine attacks on four or more days per month, or who uses acute headache medication more than ten days per month, or who meets criteria for chronic migraine, start prophylactic medication?

When to Start Prophylactic Medication for Migraine

This 40-year-old man should start prophylactic medication immediately based on the most recent 2021 Nature Reviews Neurology guidelines, which clearly state that preventive treatment should be considered in patients adversely affected on ≥2 days per month despite optimized acute treatment 1. Your patient meets multiple criteria with four or more migraine days monthly and excessive acute medication use (>10 days/month).

Clear Indications for Starting Prophylaxis

Your patient meets three separate criteria that mandate prophylactic therapy:

• Migraine frequency: ≥4 days per month with disability 2, 1
• Medication overuse: Using acute medications >10 days per month (guidelines recommend limiting to ≤2 days per week) 1
• Chronic migraine criteria: If headaches occur ≥15 days/month (needs clarification in your patient) 3

The 2021 guidelines emphasize that the ≥2 days per month threshold is pragmatic, not absolute 1. You must also weigh attack severity, duration, and resulting disability—not just frequency alone.

Critical Pitfall: Medication Overuse Headache Risk

Your patient is at high risk for medication-overuse headache (MOH) with >10 days/month of acute medication use. The evidence shows:

• Any butalbital/opioid use increases chronification risk 4
• Transformation occurs with just 8 days/month of opioid use or 10 days/month of triptan use 4
• MOH causes structural and functional brain changes 4

You must address this immediately by initiating prophylaxis while simultaneously limiting acute medication to ≤2 days per week 1, 4.

First-Line Prophylactic Options

Based on the 2021 Nature Reviews Neurology guidelines (most recent high-quality evidence), start with 1:

First-line medications:

• Beta-blockers: Propranolol (80-240 mg/d), metoprolol, atenolol, or bisoprolol
• Topiramate: 64 mg/d (titrate slowly—"start low, go slow")
• Candesartan: 65-66 mg/d

Second-line medications (if first-line fails or contraindicated):

• Flunarizine
• Amitriptyline (30-150 mg/d)
• Sodium valproate (contraindicated in women of childbearing potential) 1

Third-line medications:

• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) 1, 5

The 2025 American College of Physicians guideline supports this hierarchy, noting that beta-blockers and CGRP-mAbs have fewer discontinuations due to adverse events compared to topiramate 5.

Treatment Timeline and Expectations

Set realistic expectations with your patient:

• Oral preventives require 2-3 months to assess efficacy 2, 1
• CGRP monoclonal antibodies need 3-6 months for assessment 1
• Do not abandon treatment prematurely due to apparent inefficacy in early weeks 1

Once stable, consider tapering after:

• 3-6 months for episodic migraine 6
• 6-12 months for chronic migraine 6

Concurrent Management Strategy

While initiating prophylaxis, you must:

1. Limit acute medication to ≤2 days per week to prevent MOH 1, 4
2. Optimize acute treatment: Use triptans (not opioids/butalbital) for moderate-to-severe attacks 1, 7
3. Avoid interfering medications: Stop overused acute medications like ergotamine 2
4. Patient education: Explain medication-overuse headache risk and realistic timelines 2

Special Considerations for This Patient

Given the medication overuse pattern, consider:

• 100% wean of overused acute medications (can be done outpatient with slow taper or abruptly with hospitalization if needed) 4
• Provide new acute medications strictly limited to 2 days/week 4
• Consider referral to headache specialist if refractory after trying 2-3 prophylactic classes 8

Algorithm for Drug Selection

Choose based on:

1. Comorbidities: Hypertension → beta-blocker or candesartan; Depression → amitriptyline; High BMI → avoid valproate 9
2. Contraindications: Cardiovascular disease → avoid beta-blockers; Women of childbearing age → avoid valproate 1
3. Cost: Beta-blockers/amitriptyline are inexpensive; CGRP-mAbs are expensive (reserve for failures) 5
4. Tolerability: Topiramate has higher discontinuation rates due to adverse effects 5

The evidence strongly supports immediate initiation of prophylaxis in your patient to reduce migraine burden, prevent chronification, and address medication overuse before permanent brain changes occur.